Table 1.
Product Quality Attribute | Method | Reference | |
---|---|---|---|
Drug
substance |
Purity | HPLC-SEC (fluorescence emission profile, A260–A280 nm) | [12] |
Size and aggregation status | SEC-MALS/DLS | [24] | |
OAg identity and quantification | cELISA | [25] | |
OAg quantification | HPAEC-PAD | [12,23,26] | |
Total protein quantification | Micro BCA | - | |
OAg length | HPLC-SEC on extracted OAg | [26] | |
OAg O-acetylation content | 1H NMR on extracted OAg | [26] | |
Drug
product |
OAg identity and quantification | FAcE | [25] |
Size distribution | Laser diffraction | - | |
OAg and protein not adsorbed to Alhydrogel | SDS-PAGE silver staining | - |